“…We observed prevalence rates of 51.5% for S. aureus and 8.7% for MRSA; resistance to macrolides, lincosamides, aminoglycosides, and quinolones in sensitive and resistant isolates; and a higher frequency of SCCmec type IV MRSA, followed by type II. Studies addressing the prevalence of MRSA in primary care units are sparse 10 . In Brazil, only two such studies have been conducted; both were performed by the same research group in the City of Goiãnia, Goiás.…”